FDA Asks GSK, Others For Data On Asthma Drugs
The U.S. Food and Drug Administration has requested additional information from several asthma-drug makers, including GlaxoSmithKline and Novartis AG, in order to conduct further review of the drugs' safety....To view the full article, register now.
Already a subscriber? Click here to view full article